DOI: https://doi.org/10.14710/jai.v11i1.23942

Deksametason Untuk Mengurangi Respon Inflamasi Pada Bedah Jantung Berdasarkan Kadar C-Reactive Protein Plasma

Bagian Anestesiologi dan Terapi Intensif; Fakultas Kedokteran; Universitas Diponegoro/ RSUP Dr. Kariadi; Semarang, Indonesia

Published: 1 Mar 2019.

Citation Format:
Abstract

Latar belakang: Bedah jantung terbuka merupakan salah satu jenis operasi dengan trauma yang cukup besar, dalam pelaksanaannya menggunakan mesin Cardiopulmonary Bypass (CPB). Penggunaan mesin CPB menyebabkan respon inflamasi yang luas dan ditandai dengan peningkatan C-Reactive Protein (CRP). Salah satu cara untuk menekan produksi CRP ini dengan menggunakan deksametason. Dosis deksametason dengan teknik pemberian premedikasi yang sering digunakan yaitu 1 mg/kgbb dan 2 mg/kgbb.

Tujuan: Membandingkan efek deksametason dengan dosis 1 mg/kgbb dan dosis 2 mg/kgbb sebagai premedikasi terhadap kadar CRP pasca CPB pada operasi jantung.

Metode: Penelitian ini merupakan uji klinik acak yang mengikutsertakan 18 pasien bedah jantung dengan anestesi umum dan menggunakan mesin CPB. Sampel dibagi 2 kelompok, yaitu deksametason dosis 1 mg/kgbb dan dosis 2 mg/kgbb sebagai premedikasi. Membandingkan jumlah CRP pada masing-masing dosis deksametason saat praoperasi dan pascaoperasi.

Hasil: Pada penelitian ini, tidak ditemukan peningkatan yang bermakna dari kadar CRP pada kedua kelompok (deksametason 1 mg/kg [p=0,813] dan deksametason 2 mg/kg [p=0,115]). Perbandingan kadar CRP pascaoperasi antara kelompok deksametason 1 mg/kg dengan kelompok deksametason 2 mg/kg didapatkan hasil yang tidak bermakna (p=0,596),

Simpulan: Tidak didapatkan perbedaan antara pemberian premedikasi deksametason 1 mg/kg dengan deksametason 2 mg/kg dalam menurunkan respon inflamasi pada operasi jantung dengan CPB.

Note: This article has supplementary file(s).

Fulltext View|Download |  Research Instrument
Copyright Transfer Agreement
Subject
Type Research Instrument
  View (127KB)    Indexing metadata
Keywords: bedah jantung; CPB; CRP; deksametason; inflamasi; premedikasi

Article Metrics:

Article Info
Section: Original Articles
Language : ID
Recent articles
Deksametason Untuk Mengurangi Respon Inflamasi Pada Bedah Jantung Berdasarkan Kadar C-Reactive Protein Plasma Perbandingan Gambaran Histopatologi Lambung Tikus Wistar Setelah Pemberian Deksketoprofen dan Ketorolak Keamanan Penggunaan Propofol Auto-Coinduction Dibandingkan Dengan Midazolam Coinduction Berdasarkan Perubahan Hemodinamik Pada Induksi Anestesi Pasien Yang Dilakukan General Anestesi Pengukuran Optical Nerve Sheath Diameter (ONSD) untuk Monitoring Tekanan Intrakranial (TIK) di Intensive Care Unit (ICU) General Anesthesia Technique in Tetralogy of Fallot Patient Undergo Tooth Extraction Surgery Kejadian Drop Foot Setelah Anestesi Spinal Anestesi Regional pada Pasien dengan Penyakit Jantung/ Hemodinamik Tidak Stabil More recent articles
Most cited articles
Patofisiologi Penyakit Jantung Koroner Midazolam Intravena Dosis Rendah Tidak Mempengaruhi Nitric Oxide Intraperitoneal Mencit Balb/C Yang Terpapar Lipopolisakarida More cited articles
  1. Cohn LH. "Fifty years of open-heart surgery". Circulation.2003;17: 2168–70
  2. Lim M. The history of extracorporeal oxygenators. Anaesthesia. 2006;10: 984–95
  3. Buisson BC. The epidemiology of systemic inflammatory response. Intensive are Med. 2000;26(1):S64-74
  4. Laffey JG, Boylan JF, Cheng DC. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology. 2002; 97(1):215-252
  5. Lord, Janet M., Mark J. Midwinter, Yen-Fu Chen. "The Systemic Immune Response to Trauma: An Overview of Pathophysiology and Treatment." The Lancet 384.9952 (2014): 1455-465
  6. Mangano D. Biventricular function after myocardial revascularization in humans: Deterioration and recovery patterns during the first 24 hours. Anesthesiology. 1985; 62(5): 571-577
  7. Hensley FA, Martin DE, Gravlen GP. A practical approach to cardiac anesthesia. 3rd ed. Philadelphia: Lippincott Williams & Wilkins. 2003; 21:411-525
  8. Nathan,C. "Neutrophils and immunity: challenges and opportunities". Nature Reviews Immunology.2006; 6: 173–82
  9. Wesraby S. Organ dysfunction after cardiopulmonary bypass: a systemic inflamatory reaction initiated by the extracorporeal circuit. Intensive Care Med. 1999;13:89-95
  10. Shrivastava AK, Singh HV. C-reactive protein, inflammation and coronary heart disease. The Egyptian Heart Journal 2015;67:89-97
  11. Djillali A, Sebille C, Charpentier PE, Bollaert B. Effect of treatment with low dose of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002; 288:862-871
  12. Annane D, Bellissant E, Bollaert PE, Briegel J, Confalonieri M, De Gaudio R et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA. 2009; 301: 2362-2375
  13. Goodman S, Charles LS. The international sepsis forum,s controversies in sepsis: corticosteroids should be used to treat Septic Shock. Crit care. 2002; 6(5): 381-383
  14. Nicola R. Sproston, Jason J. Ashworth. Role of C-Reactive Protein at Sites of inflammation and infection. 13 April 2018
  15. Semple SJ. C-reactive protein- biological functions, cardiovascular disease and physical exercise. SAJSM. 2006;18(1):24-8
  16. Ho KM, Tan JA. Benefits and risks of corticosteroid prophylaxis
  17. in adult cardiac surgery: a dose-response meta-analysis. Circulation
  18. ;199:1853-66
  19. Sobieski MAI, Graham JD, Pappas PS, Tatooles AJ, Slaughter MS. Reducing the Effects of the Systemic Inflammatory Response to Cardiopulmonary Bypass: Can Single Dose Steroids Blunt Systemic Inflammatory Response Syndrome? ASAIO Journal. April 2008;54(2):203
  20. Jansen NJ, Van OW, Gu YJ. Endotoxin release and tumor nekrosis factor formation during cardioplumonary bypass. Ann thorac Surg 1992; 54 :744-48
  21. Miller BE. The Inflamatory response to cardiopulmonary bypass. J Cardiothorac Vasc Anesthesia. 1997;11:355-66
  22. Donihi AC, Raval D, Saul M, Korytkowski MT, DeVita MA (2006). "Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients". Endocr Pract. 12(4): 358–62
  23. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD: Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1983; 86:845-57
  24. Whitlock RP, Chan S, Devereaux PJ, Sun J, Rubens FD, Thorlund K, dkk. Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials. European Heart Journal. 20 Mei 2008;29(21):2592–600
  25. Aouifi A, Piriou V, Blanc P, Bouvier H, Bastien O, Chiari P, dkk. Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations. British Journal of Anaesthesia. Oktober 1999;83(4):602–7
  26. Dieleman JM, Nierich AP, Rosseel PM, Maaten JM van der, Hofland J, Diephuis JC, dkk. Intraoperative High-Dose Dexamethasone for Cardiac Surgery: A Randomized Controlled Trial. JAMA. 7 November 2012;308(17):1761–7
  27. Murphy GS, Sherwani SS, Szokol JW, Avram MJ, Greenberg SB, Patel KM, dkk. Small-Dose Dexamethasone Improves Quality of Recovery Scores After Elective Cardiac Surgery: A Randomized, Double-Blind, Placebo-Controlled Study. Journal of Cardiothoracic and Vascular Anesthesia. 1 Desember 2011;25(6):950–60

Last update:

No citation recorded.

Last update: 2024-04-19 20:55:11

No citation recorded.